Jazz Pharmaceuticals Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -2.24%123.780.0%$415.28m
ICLRICON plc 3.86%217.582.8%$327.83m
VRXValeant Pharmaceuticals International, Inc. 0.42%28.7114.1%$168.93m
HZNPHorizon Therapeutics Plc 0.97%101.045.5%$131.45m
JAZZJazz Pharmaceuticals Plc 0.08%173.952.2%$88.41m
CTLTCatalent, Inc. 0.96%116.302.1%$77.98m
PRGOPerrigo Co. Plc 1.09%46.326.9%$51.39m
UTHRUnited Therapeutics Corp. -0.39%185.0714.0%$49.16m
ENDPEndo International Plc 1.33%4.968.6%$43.98m
BHCBausch Health Cos., Inc. 0.42%28.710.0%$43.91m
ARGXargenx SE -0.02%316.510.0%$40.71m
SAGESAGE Therapeutics, Inc. -1.40%45.137.6%$34.54m
IRWDIronwood Pharmaceuticals, Inc. 0.65%13.089.6%$28.47m
ZGNXZogenix, Inc. 3.65%17.877.5%$23.73m
AXSMAxsome Therapeutics, Inc. -3.70%53.811.9%$19.97m

Company Profile

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.